CLB FY 2017 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2017 Earnings

Reported February 9, 2018

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$660M	—	$595M	—	10.9%
Op. Income	$112M	—	$86M	—	30.5%
Gross Margin	24.3%	—	21.1%	—	3.3pp
Net Margin	12.6%	—	10.7%	—	1.9pp
EPS (Diluted)	$1.88	—	$1.45	—	29.7%
Free Cash Flow	$105M	—	$120M	—	-12.2%

Revenue Flow

Item	Amount
REVENUE	$660M
Cost of Revenue	$499M
GROSS PROFIT	$161M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$48M
SG&A Expenses	$48M
Other Expenses	-$452.0K
Operating Expenses	$48M
Cost & Expenses	$547M
OPERATING INCOME	$112M
Interest Income	$0
Interest Expense	$11M
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$102M
Income Tax Expense	$19M
Net Income from Continuing Ops	$81M
Net Income from Discontinued Ops	$2M
Other Adjustments	$0
NET INCOME	$83M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$83M
D&A	$25M
EBIT	$110M
EBITDA	$134M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$660M
Cost of Revenue	$499M
GROSS PROFIT	$161M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$48M
SG&A Expenses	$48M
Other Expenses	-$452.0K
Operating Expenses	$48M
Cost & Expenses	$547M
OPERATING INCOME	$112M
Interest Income	$0
Interest Expense	$11M
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$102M
Income Tax Expense	$19M
Net Income from Continuing Ops	$81M
Net Income from Discontinued Ops	$2M
Other Adjustments	$0
NET INCOME	$83M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$83M
D&A	$25M
EBIT	$110M
EBITDA	$134M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$83M
Depreciation & Amortization	$25M
Stock-Based Compensation	$23M
Deferred Income Tax	$9M
Other Non-Cash Items	-$6M
Change in Working Capital	-$9M
OPERATING CASH FLOW	$124M
Capital Expenditure	-$19M
Acquisitions (Net)	$0
Purchases of Investments	-$2M
Sales/Maturities of Investments	$0
Other Investing Activities	-$18M
NET CASH FROM INVESTING	-$21M
Net Debt Issuance	$10M
Common Stock Repurchased	-$17M
Common Dividends Paid	-$97M
Other Financing Activities	-$26.0K
NET CASH FROM FINANCING	-$104M
FREE CASH FLOW	$105M
Net Change in Cash	-$364.0K

Balance Sheet

Item	Amount
Cash & Equivalents	$14M
Short-Term Investments	$0
Net Receivables	$133M
Inventory	$33M
Other Current Assets	$14M
TOTAL CURRENT ASSETS	$207M
PP&E (Net)	$123M
Goodwill	$179M
Intangible Assets	$9M
Long-Term Investments	$4M
Tax Assets	$11M
Other Non-Current Assets	-$14M
TOTAL NON-CURRENT ASSETS	$377M
TOTAL ASSETS	$585M
Account Payables	$42M
Short-Term Debt	$0
Deferred Revenue	$17M
Other Current Liabilities	$30M
TOTAL CURRENT LIABILITIES	$105M
Long-Term Debt	$227M
Deferred Revenue NC	-$5M
Deferred Tax Liabilities	$5M
Other Non-Current Liabilities	$46M
TOTAL NON-CURRENT LIABILITIES	$331M
TOTAL LIABILITIES	$436M
Common Stock	$1M
Additional Paid-In Capital	$54M
Retained Earnings	$174M
Treasury Stock	-$76M
Accum. Other Comp. Income	-$8M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$149M
Minority Interest	$4M
TOTAL EQUITY	$153M
TOTAL LIABILITIES & EQUITY	$585M
Total Debt	$227M
Net Debt	$213M